PharmaEssentia Corporation (6446.TW)
TWD 572.0
(-1.38%)
TWD 572.0
(-1.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 5.1 Billion | 2.88 Billion | 656.5 Million | 557.25 Million | 305.69 Million |
| Cost of Revenue | 610.54 Million | 812.28 Million | 378.85 Million | 373.32 Million | 61.7 Million |
| Gross Profit | 4.49 Billion | 2.06 Billion | 277.65 Million | 183.93 Million | 243.98 Million |
| Operating Expenses | 4.49 Billion | 4.09 Billion | 3.1 Billion | 1.89 Billion | 1.08 Billion |
| Selling, General and Administrative Expenses | 4.18 Billion | 2.67 Billion | 1.82 Billion | 977.4 Million | 453.63 Million |
| Research and Development Expenses | 2.22 Billion | 1.42 Billion | 1.27 Billion | 922.38 Million | 639.57 Million |
| Other Expenses | - | 164.4 Million | 16.75 Million | -231.4 Million | - |
| Cost and Expenses | 7.01 Billion | 4.91 Billion | 3.47 Billion | 2.27 Billion | 1.14 Billion |
| Operating Income | - | -1.82 Billion | -2.8 Billion | -1.93 Billion | -849.22 Million |
| Interest Expense | 46.69 Million | 18.52 Million | 9.97 Million | 8.25 Million | - |
| Income Tax Expense | -363.09 Million | -467.06 Million | - | 126 Thousand | 850 Thousand |
| Earnings before Tax | -986.93 Million | -1.84 Billion | -2.81 Billion | -1.94 Billion | -842.14 Million |
| Net Income | -623.83 Million | -1.37 Billion | -2.81 Billion | -1.94 Billion | -842.99 Million |
| Earnings Per Share Basic | -1.93 | -4.84 | -10.80 | -7.94 | -3.85 |
| Earnings Per Share Diluted | -1.93 | -4.84 | -10.80 | -7.94 | -3.85 |
| Weighted Average Shares Outstanding | 322.47 Million | 284.2 Million | 260.16 Million | 245.31 Million | 219.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 322.47 Million | 284.2 Million | 260.16 Million | 245.31 Million | 219.13 Million |
| Gross Margin | 0.88 | 0.72 | 0.42 | 0.33 | 0.80 |
| EBIT Margin | -0.13 | -0.55 | -3.92 | -3.17 | -2.54 |
| Profit Margin | -0.12 | -0.48 | -4.28 | -3.50 | -2.76 |
| EBITDA | -671.48 Million | -1.59 Billion | -2.57 Billion | -1.76 Billion | -775.31 Million |
| Earnings Before Tax Margin | - | -0.63 | -4.27 | -3.48 | -2.78 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.3 Billion | 1.65 Billion | 1.64 Billion | 5.1 Billion | 1.3 Billion | 1.26 Billion |
| Cost of Revenue | 300.39 Million | 193.22 Million | 251.51 Million | 610.54 Million | 121.78 Million | 104.07 Million |
| Gross Profit | 2 Billion | 1.46 Billion | 1.39 Billion | 4.49 Billion | 1.18 Billion | 1.16 Billion |
| Operating Expenses | 1.56 Billion | 1.44 Billion | 1.52 Billion | 6.4 Billion | 1.82 Billion | 1.56 Billion |
| Selling, General and Administrative Expenses | 970.34 Million | 919.1 Million | 954.99 Million | - | 1.04 Billion | 1.08 Billion |
| Research and Development Expenses | 593.2 Million | 523.52 Million | 572.46 Million | - | 785.56 Million | 475.83 Million |
| Other Expenses | 255.01 Million | 101.7 Million | -290.05 Million | 388.02 Million | 621.56 Million | 89.31 Million |
| Cost and Expenses | 1.86 Billion | 1.63 Billion | 1.77 Billion | 7.01 Billion | 1.95 Billion | 1.66 Billion |
| Operating Income | 932.71 Million | 339.71 Million | -208.69 Million | -940.24 Million | 194.79 Million | -185.45 Million |
| Interest Expense | 6.21 Million | 5.11 Million | 6.04 Million | 46.69 Million | 3.93 Million | 17.59 Million |
| Income Tax Expense | 246.68 Million | 4.21 Million | -330.67 Million | -363.09 Million | -7.65 Million | -296 Thousand |
| Earnings before Tax | 926.5 Million | 334.6 Million | -214.73 Million | -986.93 Million | 190.86 Million | -203.05 Million |
| Net Income | 679.82 Million | 330.38 Million | 115.93 Million | -623.83 Million | 198.52 Million | -202.75 Million |
| Earnings Per Share Basic | 2.09 | 1.00 | 0.35 | - | 0.67 | -0.62 |
| Earnings Per Share Diluted | 2.07 | 0.99 | 0.35 | - | 0.66 | -0.62 |
| Weighted Average Shares Outstanding | 325.27 Million | 330.48 Million | 331.87 Million | 322.47 Million | 296.3 Million | 327.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 328.41 Million | 333.61 Million | 330.01 Million | 322.47 Million | 300.79 Million | 327.02 Million |
| Gross Margin | 0.87 | 0.88 | 0.85 | 0.88 | 0.91 | 0.92 |
| EBIT Margin | 0.44 | 0.26 | -0.06 | - | 0.19 | -0.10 |
| Profit Margin | 0.29 | 0.20 | 0.07 | -0.12 | 0.15 | -0.16 |
| EBITDA | 1.02 Billion | 428.27 Million | -106.31 Million | - | 254.21 Million | -129.5 Million |
| Earnings Before Tax Margin | 0.40 | 0.21 | -0.13 | -0.18 | 0.15 | -0.15 |
SROYF
PUBLI
EUREKAI
1268
SLL
CHEF